The Chronic Disease of Addiction Evidence and Lessons from Practice

Similar documents
THE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D.

Treating Addiction as a Chronic Disease

Addiction Epidemiology, Language and Stigma

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Methadone and Naltrexone ER

Mass General s Substance Use Disorder Initiative

Methadone and Naltrexone ER

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Opioid Use Disorder Treatment Initiation in Diverse Settings

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

Treatment Approaches for Drug Addiction

MGH Substance Use Disorder Initiative. Dawn Williamson, RN, DNP, PMHCNS-BC, CARN-AP MGH ED Christopher Shaw, RN, ANP, PMHNP-BC, CARN-AP MGH ACT

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Alcohol 2: Case Examples

Opioid Use Disorder Treatment: Buprenorphine Treatment Basics

Addicted, Alone, Forgotten, and Ashamed

Understanding Addiction: Why Can t Those Affected Just Say No?

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017

Neurobiology of Addiction

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

The Importance of Psychological Treatment and Behavioral Support

6/27/2017. Disclosures. Overview. Case Overview

Opioid Use Disorders &Medication Treatment

STARTING SUBOXONE IN PRIMARY CARE

BASIC VOLUME. Elements of Drug Dependence Treatment

Opioids Research to Practice

Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director

Medical Assisted Treatment of Opioid

Opioid Withdrawal, Opioid Substitution, and HIV Infection

WHAT CAN I EXPECT?: DUAL SUBSTANCE USE AND MENTAL HEALTH TREATMENT FOR MILITARY POPULATIONS

Medication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment

The science of the mind: investigating mental health Treating addiction

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Opioids Research to Practice

ADDICTION OBJECTIVES 4/10/2018 DISCLOSURE

John Murphy DO, MS Lynx Healthcare

Vivitrol Drug Court and Medication Assisted Treatment

Management of Opioid Use Disorder in Primary Care

What are Substance Use Disorders?

Pharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco

III. FREQUENTLY ASKED QUESTIONS

Serious Mental Illness and Opioid Use Disorder

OUD & MAR: Caring for Our Communities

Medical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

Brain Health and Opioid Abuse

Understanding the Brain: What Drugs Can Tell Us

Understanding Addiction. Understanding Addiction. Acknowledgements. KP Regional Pain Symposium August 8, Mary Eno MD, MPH

Learning Objectives. Serving Pregnant Women Affected by Substance Use Disorders in Healing to Wellness Court: Sharing Lessons

Infectious Disease and the Opioid Epidemic: Correctional Health

Neuroscience of Addiction

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Opioid Withdrawal, Opioid Substitution, and HIV Infection

Addressing Opiate Abuse

2/24/2017. Pregnant Women Who Use Drugs: Stigma, Science and Society

DISCLOSURES MANAGEMENT OF OPIOID USE DISORDERS LECTURE COVERS. SUDs ARE IMPORTANT. I have nothing to declare

Interdisciplinary Management of Opioid Use Disorder in Rural Primary Care Settings

Safina Koreishi, MD, MPH, Medical Director, Columbia Pacific CCO

Medication Assisted Treatment of Substance Use Disorders

FLAME TEEN HANDOUT Week 9 - Addiction

OPIOID USE DISORDER (OUD) TREATMENT IN A PATIENT CENTERED HEALTH CENTER

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Opioid Use and Justice Involvement: Challenges in Treatment, Engagement, and Continuity

Opioids Research to Practice

ADAPTING YOUR COURT STRUCTURE

4/19/2018. Opioid Use Disorder in Pregnancy OBJECTIVES ANTENATAL TESTING

NALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018

Opioid Task Force Kick-Off Meeting. February 29, 2016

Harm Reduction and Medical Respite (Dead People Don t Recover) Alice Moughamian, RN,CNS Dave Munson MD

Buprenorphine 2.0: I have my waiver, now what? Dr. Ritu Bhatnagar, M.D., M.P.H. Dr. John Ewing, M.D., FASAM. Disclosures

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018

Introduction to the Massachusetts Consultation Service for the Treatment of Addiction and Pain. March 12 and March 13, 2019

Identification and Treatment of Opioid Use Disorders in Primary Care Settings

Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection

Patient-Focused Drug Development for Opioid Use Disorder

Concurrent Disorders

Treating Opioid Addiction

Medication Treatment and Opioid Use Disorder

MAT in the Corrections Setting

Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

Recognizing Narcotic Abuse and Addiction and Helping Those With It

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

Prescription Opioid Addiction

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

CFHA 18 th Annual Conference October 13-15, 2016 Charlotte, NC U.S.A. Session # A1

Approaches to Treatment of Youth with Opioid Addiction

Intro to Concurrent Disorders

BENZODIAZEPINES: WHAT YOU DON T KNOW CAN HURT YOU

Homelessness and Poor Health: Housing as Treatment

The Opioid Crisis: What Can Physicians Do About It?

Adolescents And Addiction

Johann Hari. Truths 2/29/2016. From the street to the NICU. Treatment works

OPIOID SAFE- PRESCRIBING TRAINING IMMERSION (OSTI)

Tobacco Dependence Treatment From Neurobiology through Public Policy

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Transcription:

The Chronic Disease of Addiction Evidence and Lessons from Practice Laura G. Kehoe, MD, MPH Medical Director, MGH Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Assistant Professor of Medicine, Harvard Medical School

Disclosures I have the following relevant financial relationship with a commercial interest to disclose Guest lecture honoraria Reckitt Benckiser

Objectives Review of chronic, relapsing model of addiction Comparison with other chronic diseases Lessons from practice Lessons from patients

Addiction is Irrational Primary, chronic brain disease characterized by compulsive drug seeking and use despite harmful consequences Involves cycles of relapse and remission 40-60% genetic Without treatment addiction is progressive and can result in disability or premature death American Society of Addiction Medicine. April 12, 2011. www.asam.org NIDA. August, 2010. http://www.drugabuse.gov/publications/science-addiction

Addiction is a Developmental Disease

Childhood Dreams and Aspirations

Acute Care Model As We Know It overdose relapse detox detox relapse overdose Treatment

Can You Guess?

Circuits Involved in Addiction NIDA

Bmax/Kd DA D2 Receptors (Ratio Index) Dopamine D2 Receptors are Lower in Addiction 4.5 4 Normal Controls Cocaine Abusers Cocaine 3.5 3 2.5 Meth 2 1.5 15 20 25 30 35 40 45 50 Alcohol 3.2` 3 2.8 2.6 2.4 2.2 2 1.8 Heroin 20 25 30 35 40 45 50 control addicted Volkow et al., Neuro Learn Mem 2002. 1.6

Withdrawal Normal Euphoria Natural History of Opioid Use Disorder Tolerance & Physical Dependence Acute use Chronic use Slide courtesy of Dan Alford, 2012

Addiction is Similar to Heart Disease Decreased Heart Metabolism in Coronary Artery Disease High Decreased Brain Metabolism in Addiction Healthy heart Diseased Heart Low Healthy Brain Diseased Brain

Functional Recovery Takes Time Normal 1 month postdetox 14 months Source: Volkow, ND et al., Journal of Neuroscience 21, 9414-9418, 2001

Addiction is a Treatable Disorder NIDA. Principles of Drug Addiction Treatment. 2012. McLellan et al., JAMA, 284:1689-1695, 2000.

Comparable Relapse Rates Slide courtesy of NIDA, Drugs, Brain Behavior: the Science of Addiction

Extended Abstinence is Predictive of Sustained Recovery After 5 years if you are sober, you probably will stay that way. It takes a year of abstinence before less than half relapse Dennis et al, Eval Rev, 2007 Slide courtesy of NIDA, Drugs, Brain Behavior: the Science of Addiction

Treating a Biobehavioral Disorder Must Go Beyond Just Fixing the Chemistry Pharmacological Treatments (Medications) We Need to Treat the Whole Person! Behavioral Therapies Medical Services Social Services In Social Context Slide courtesy of NIDA, Drugs, Brain Behavior: the Science of Addiction

Stacey Stacey is a 43 yof with severe OUD, remote cocaine use disorder, tobacco use disorder, COPD with recurrent pneumonia, marital discord, DCF involvement, trauma. Starts Suboxone with stabilization at 20 mg daily eventually Engaged and in remission x 12 mo, reunited with children, working Needs lung biopsy, makes it through with increase Suboxone and support Rx Tramadol from surgeon - relapse Re-engages stabilizes x 9 months Cravings in setting of custody battle, Rx adjusted Stabilizes with increased support, stress reduction, tx of her anxiety After another year, has pelvic surgery, pain, increased anxiety increase Suboxone and supports did well Note: regarding courts

Stephen Stephen is a 40 yom with long hx IVDU heroin, trauma, short stint in the reserves, and now homelessness. My first pt on Suboxone. Immediate engagement, feels normal, gets back to classes, ongoing insomnia 12 step meetings Early refill request UTOX + cocaine, THC Missed appt due to class On nightly news holding up a CVS for OxyContin

Stephen Returned to clinic on probation Resumed Rx with shorter visit intervals, support, shorter Rx supplies, engagement in counselling, contingency mgmt, GAD treatment Engagement with VA housing Stabilizes on higher dose Suboxone and increased support Periodic relapses, each shorter Now in remission 2+ years

Relapse Requires Increased Support We label patients as not ready or non compliant We ask them to seek a higher level of care on their own, when most ill We refer them for higher level of care yet many of those programs are not evidence based, and are essentially lower level of care What would we do if a cancer survivor had a lymphoma recurrence after years of remission?

People Don t Fail Treatment. Treatment Fails People Ed Salsitz, MD Deconstruct the relapse with your patient Good people make bad decisions when SUD active Change takes time, patience and trust When diseases flare, we increase care or enlist the care of other team members. This is no different Trust is an important tool Positive reinforcement (contingency management) Competing priorities Communicate with others No one size fits all just like other diseases Diet controlled pre-diabetes, oral agents, insulin for DM Diet, exercise, statin, beta-blocker, ASA, ACE inhibitors for heart disease

Lessons Learned Listen to your patients It s hard to have an addiction Diversion happens Most have used Suboxone in the past and can do home inductions Don t get caught up in the dose- splitting hairs Don t forget about pseudo-addiction Take sleep disturbance seriously advance Suboxone Take report of cravings extremely seriously treat

What Next?

Our Roles